Riskpilot← Back to searchSign inGet full accessSKIPPERGATA APOTEK AS
ASActiveOrg 911797259Nedre Prinsdals Vei 70, 1263 OsloRetail sale of pharmaceutical products · NACE 4773Est. 20130 employees
Revenue 2022
NOK 16,5M
-19% vs 2021
EBITDA margin
2.0%
-77% vs 2021
Equity ratio
26.7%
Financial strength
Net profit 2022
NOK 153K
-85% vs 2021
| Revenue | NOK 16,5M | -19% |
| EBITDA | NOK 329K | -77% |
| Net profit | NOK 153K | -85% |
| Total assets | NOK 3,1M | -36% |
| Equity | NOK 837K | +0% |
| Employees | 0 | — |
Legal name
SKIPPERGATA APOTEK AS
Org number
911797259
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
9. april 2013
Share capital
NOK 812 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Nedre Prinsdals Vei 70, 1263 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 8 014 | 13 409 | 18 470 | 20 268 | 16 499 |
| Staff expenses | −1 594 | −2 506 | −3 146 | −3 265 | −3 225 |
| EBITDA | 128 | 360 | 1 258 | 1 443 | 329 |
| Depreciation & amort. | −154 | −232 | −232 | −180 | −159 |
| EBIT | −26 | 128 | 1 026 | 1 263 | 170 |
| Net financials | −25 | −25 | 2 | 19 | 29 |
| Profit before tax | −51 | 103 | 1 028 | 1 282 | 199 |
| Tax | −0 | −0 | 78 | 284 | 46 |
| Net profit | −51 | 103 | 950 | 998 | 153 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 3 105 | 3 458 | 4 598 | 4 930 | 3 136 |
| Equity | 743 | 846 | 836 | 834 | 837 |
| Long-term debt | 864 | 679 | 13 | 4 | 0 |
| Short-term debt | 1 498 | 1 933 | 3 750 | 4 092 | 2 299 |
| Total debt | 2 362 | 2 612 | 3 762 | 4 096 | 2 299 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20182022
Equity ratio
26.7%
This company
38.2%
Market median
-30% vs market
20182022
Return on equity
18.3%
This company
18.4%
Market median
+1% vs market
20182022
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20182022
Asset turnover
5.26×
This company
1.12×
Market median
+370% vs market
20182022
Debt / equity
2.75×
This company
0.62×
Market median
-344% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
SI Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
SM Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
GA Chief Executive Officer | Chief Executive Officer | 2018 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (3) | ||
| Chairman | 2018 – 2023 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
SKIPPERGATA APOTEK AS Board members of SKIPPERGATA APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Saleem Iqbal | Chief Executive Officer | 0 companies |
| Sabrin Moueffaq | Chief Executive Officer | 0 companies |
| Gulzeb Aziz | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |